Hemostasis & Thrombosis Specialty Areas
Hemophilia Treatment Center
The Johns Hopkins Hemophilia Treatment Center provides comprehensive, multidisciplinary care for individuals with congenital or acquired bleeding disorders. We care for patients with a wide range of bleeding disorders such as Hemophilia A (Factor VIII deficiency), Hemophilia B (Factor IX deficiency), von Willebrand Disease (vWD), and other congenital and acquired factor inhibitors.Our Center is a member of the federally-funded Hemophilia Treatment Centers (HTCs) Network.
Hemostatic & Antithrombotic Stewardship Program
Patients with bleeding and clotting disorders often require medications to prevent severe complications. However, these medications can be high-risk if not administered by an expert team and are often associated with high cost. The mission of the Johns Hopkins Hemostatic & Antithrombotic Stewardship Program is to provide the highest quality of care to patients with bleeding and clotting disorders while reducing unwanted costs.
Our Johns Hopkins Hemostatic & Antithrombotic Stewardship Program is a unique collaboration between the Division of Hematology and Department of Pharmacy. Our team runs a factor approval service, develops evidence-based institutional guidelines for the proper use of bleeding/clotting agents, and provides real-time advice to our Hematology Inpatient team.